Gibney Anthony S
Insider CIK 1750132 · ACHN EVP, Chief Business Officer · ISEE EVP, Chief Business Officer · AURA See Remarks · CLSD Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AURA Aura Biosciences, Inc. | S Sale | 2026-06-16 | 2026-06-16 | 12,824 | $6.42 | $82.3K | 265,354 | SEC↗ |
| AURA Aura Biosciences, Inc. | A Award deriv | 2026-03-02 | 2026-03-03 | 128,755 | — | $0 | 128,755 | SEC↗ |
| AURA Aura Biosciences, Inc. | A Award | 2026-03-02 | 2026-03-03 | 71,245 | — | $0 | 278,178 | SEC↗ |
| AURA Aura Biosciences, Inc. | A Award deriv | 2025-06-02 | 2025-06-04 | 250,000 | — | $0 | 250,000 | SEC↗ |
| AURA Aura Biosciences, Inc. | A Award | 2025-06-02 | 2025-06-04 | 150,000 | — | $0 | 206,933 | SEC↗ |
| AURA Aura Biosciences, Inc. | P Buy deriv | 2025-05-16 | 2025-05-20 | 12,500 | — | $0 | 12,500 | SEC↗ |
| AURA Aura Biosciences, Inc. | S Sale | 2025-05-16 | 2025-05-20 | 1,519 | $5.15 | $7.8K | 56,933 | SEC↗ |
| AURA Aura Biosciences, Inc. | P Buy | 2025-05-16 | 2025-05-20 | 50,000 | $4.90 | $245.0K | 58,452 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | A Award deriv | 2024-06-20 | 2024-06-21 | 45,000 | — | $0 | 45,000 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | P Buy | 2024-04-18 | 2024-04-19 | 93,290 | $1.30 | $121.3K | 100,000 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | P Buy | 2024-04-17 | 2024-04-19 | 6,710 | $1.25 | $8.4K | 6,710 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | A Award deriv | 2024-04-15 | 2024-04-16 | 45,000 | — | $0 | 45,000 | SEC↗ |
| ISEE IVERIC bio, Inc. | D To issuer deriv | 2023-07-11 | 2023-07-13 | 56,250 | — | $0 | 0 | SEC↗ |
| ISEE IVERIC bio, Inc. | D To issuer deriv | 2023-07-11 | 2023-07-13 | 25,000 | — | $0 | 0 | SEC↗ |
| ISEE IVERIC bio, Inc. | D To issuer deriv | 2023-07-11 | 2023-07-13 | 75,000 | — | $0 | 0 | SEC↗ |
| ISEE IVERIC bio, Inc. | D To issuer deriv | 2023-07-11 | 2023-07-13 | 50,000 | — | $0 | 0 | SEC↗ |
| ISEE IVERIC bio, Inc. | D To issuer deriv | 2023-07-11 | 2023-07-13 | 200,000 | — | $0 | 0 | SEC↗ |
| ISEE IVERIC bio, Inc. | D To issuer | 2023-07-11 | 2023-07-13 | 40,291 | — | $0 | 0 | SEC↗ |
| ISEE IVERIC bio, Inc. | G Gift | 2023-06-28 | 2023-06-30 | 2,500 | — | $0 | 40,291 | SEC↗ |
| ISEE IVERIC bio, Inc. | A Award deriv | 2022-12-20 | 2022-12-22 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ISEE IVERIC bio, Inc. | A Award deriv | 2022-12-20 | 2022-12-22 | 50,000 | — | $0 | 50,000 | SEC↗ |
| ISEE IVERIC bio, Inc. | M Exercise deriv | 2022-12-13 | 2022-12-14 | 6,000 | — | $0 | 0 | SEC↗ |
| ISEE IVERIC bio, Inc. | M Exercise deriv | 2022-12-13 | 2022-12-14 | 25,000 | — | $0 | 75,000 | SEC↗ |
| ISEE IVERIC bio, Inc. | M Exercise | 2022-12-13 | 2022-12-14 | 25,000 | — | $0 | 42,791 | SEC↗ |
| ISEE IVERIC bio, Inc. | M Exercise | 2022-12-13 | 2022-12-14 | 6,000 | — | $0 | 17,791 | SEC↗ |
| ISEE IVERIC bio, Inc. | S Sale | 2022-07-05 | 2022-07-05 | 7,791 | $9.41 | $73.3K | 10,959 | SEC↗ |
| ISEE IVERIC bio, Inc. | M Exercise deriv | 2022-06-30 | 2022-07-05 | 18,750 | — | $0 | 56,250 | SEC↗ |
| ISEE IVERIC bio, Inc. | M Exercise | 2022-06-30 | 2022-07-05 | 18,750 | — | $0 | 18,750 | SEC↗ |
| ISEE IVERIC bio, Inc. | A Award deriv | 2021-12-13 | 2021-12-15 | 6,000 | — | $0 | 6,000 | SEC↗ |
| ISEE IVERIC bio, Inc. | A Award deriv | 2021-12-13 | 2021-12-15 | 75,000 | — | $0 | 75,000 | SEC↗ |
| ISEE IVERIC bio, Inc. | A Award deriv | 2021-12-13 | 2021-12-15 | 100,000 | — | $0 | 100,000 | SEC↗ |
| ISEE IVERIC bio, Inc. | A Award deriv | 2021-12-13 | 2021-12-15 | 200,000 | — | $0 | 200,000 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | D To issuer deriv | 2020-01-28 | 2020-01-29 | 200,000 | — | $0 | 0 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | D To issuer deriv | 2020-01-28 | 2020-01-29 | 500,000 | — | $0 | 0 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | A Award deriv | 2019-01-23 | 2019-01-25 | 200,000 | — | $0 | 200,000 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | A Award deriv | 2018-08-15 | 2018-08-16 | 500,000 | — | $0 | 500,000 | SEC↗ |